Multiplex Serum Biomarker Analysis before and during Therapy with Canakinumab in Patients with Systemic Juvenile Idiopathic Arthritis

被引：0
|
作者：
Hinze, Tanja [1 ]
Kessel, Christoph [1 ]
Hinze, Claas [1 ]
Seibert, Julia [2 ]
Gram, Hermann [2 ]
Foell, Dirk [3 ]
机构：
[1] Univ Munster, Dept Pediat Rheumatol & Immunol, Munster, Germany
[2] Novartis, Basel, Switzerland
[3] Univ Munster, Pediat Rheumatol & Immunol, Munster, Germany
来源：
ARTHRITIS & RHEUMATOLOGY | 2018年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2917
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Long term efficacy and safety of canakinumab in children with systemic juvenile idiopathic arthritis with and without fever
    Horneff G.
    Ruperto N.
    Brunner H.
    Quartier P.
    Constantin T.
    Alexeeva E.
    Kone-Paut I.
    Marzan K.
    Wulffraat N.
    Schneider R.
    Padeh S.
    Chasnyk V.
    Wouters C.
    Deschner J.K.
    Kallinich T.
    Lauwerys B.
    Haddad E.
    Nasonov E.
    Trachana M.
    Vougiouka O.
    Abrams K.
    Leon K.
    Lheritier K.
    Martini A.
    Lovell D.
    [J]. Pediatric Rheumatology, 13 (Suppl 1)
  • [42] CANAKINUMAB IN SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: IMPACT ON THE RATE AND CLINICAL PRESENTATION OF MACROPHAGE ACTIVATION SYNDROME
    Grom, A. A.
    Brunner, H. I.
    Ruperto, N.
    Martini, A.
    Lovell, D.
    Pascual, V.
    Lheritier, K.
    Abrams, K.
    Ilowite, N.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 578 - 578
  • [43] Canakinumab First or Second Choice in Systemic Juvenile Idiopathic Arthritis Experience from Clinical Practice
    Horneff, Gerd
    Foeldvari, Ivan
    Tenbrock, Klaus
    Minden, K.
    Kuemmerle-Deschner, Jasmin B.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [44] Exposure-Response Modeling Of Canakinumab In The Avoidance Of Flares In Children With Systemic Juvenile Idiopathic Arthritis
    Xiong, Yuan
    Wang, Wenping
    Ebling, William
    Sun, Haiying
    Luttringer, Olivier
    Abrams, Ken
    Ruperto, Nicola
    Brunner, Hermine
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S865 - S866
  • [45] CHANGES IN HEALTH-RELATED QUALITY OF LIFE IN SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS PATIENTS AFTER SINGLE DOSE OF CANAKINUMAB
    Wulffraat, N.
    Kallinich, T.
    McCann, L.
    Brik, R.
    Rutkowska-Sak, L.
    Ferrandiz, M.
    Lheritier, K.
    Kim, D.
    Gnanasakthy, A.
    Ozdogan, H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 266 - 267
  • [46] Pivotal Phase III study demonstrates substantial symptom relief in patients with systemic juvenile idiopathic arthritis treated with canakinumab
    不详
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2011, 7 (06) : 721 - 721
  • [47] Serum Leucine-Rich 2-Glycoprotein as a Biomarker for Monitoring Disease Activity in Patients with Systemic Juvenile Idiopathic Arthritis
    Shimizu, Masaki
    Inoue, Natsumi
    Mizuta, Mao
    Nakagishi, Yasuo
    Yachie, Akihiro
    [J]. JOURNAL OF IMMUNOLOGY RESEARCH, 2019, 2019
  • [48] Serum thrombomodulin in systemic lupus erythematosus and juvenile idiopathic arthritis
    El-Gamal, YM
    Heshmat, NM
    El-Kerdany, TH
    Fawzy, AF
    [J]. PEDIATRIC ALLERGY AND IMMUNOLOGY, 2004, 15 (03) : 270 - 277
  • [49] CANAKINUMAB IS A RESCUE TREATMENT FOR MACROPHAGE ACTIVATION SYNDROME IN PATIENTS WITH SYSTEMIC ONSET JUVENILE IDIOPATHIC ARTHRITIS: SINGLE CENTER EXPERIENCE
    Kostik, M.
    Isupova, E.
    Chikova, I.
    Likhacheva, T.
    Masalova, V.
    Snegireva, L.
    Dubko, M.
    Gaidar, E.
    Kaneva, M.
    Kornishina, T.
    Kalashnikova, O.
    Chasnyk, V.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 937 - 937
  • [50] Reasons for Initiation of Canakinumab of Patients with Systemic Juvenile Idiopathic Arthritis: A Retrospective Medical Chart Review from the United States
    Hur, Peter
    Ionescu-Ittu, Raluca
    Manceur, Ameur M.
    Lomax, Kathleen G.
    Cammarota, Jordan
    Xie, Jipan
    Sanghera, Navneet
    Grom, Alexei A.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
12345